Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease

Summary

This is a single-center, double-blind, inpatient study followed by an outpatient, placebo-controlled, multiple-IV injection evaluation of the safety and tolerability of PPI-1019 in subjects with mild-moderate Alzheimer's disease (AD). The primary objective of the study is to assess the safety of multiple IV injections of PPI-1019 in subjects with mild-moderate Alzheimer's disease.

Timeline

Start

2004-12

Primary completion

—

Completion

2005-08

Drugs

Indications